Effect of route of administration and effusions on methotrexate pharmacokinetics. 1974

S H Wan, and D H Huffman, and D L Azarnoff, and R Stephens, and B Hoogstraten

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010534 Peritoneal Neoplasms Tumors or cancer of the PERITONEUM. Peritoneal Carcinomatosis,Peritoneal Surface Malignancy,Carcinomatosis, Peritoneal,Malignancy, Peritoneal Surface,Neoplasm, Peritoneal,Peritoneal Carcinomatoses,Peritoneal Neoplasm,Peritoneal Surface Malignancies,Surface Malignancy, Peritoneal
D010996 Pleural Effusion Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself. Effusion, Pleural,Effusions, Pleural,Pleural Effusions
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D005260 Female Females

Related Publications

S H Wan, and D H Huffman, and D L Azarnoff, and R Stephens, and B Hoogstraten
January 1982, Cancer chemotherapy and pharmacology,
S H Wan, and D H Huffman, and D L Azarnoff, and R Stephens, and B Hoogstraten
November 2002, Cancer chemotherapy and pharmacology,
S H Wan, and D H Huffman, and D L Azarnoff, and R Stephens, and B Hoogstraten
January 2020, Open life sciences,
S H Wan, and D H Huffman, and D L Azarnoff, and R Stephens, and B Hoogstraten
December 1986, Clinical pharmacy,
S H Wan, and D H Huffman, and D L Azarnoff, and R Stephens, and B Hoogstraten
June 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
S H Wan, and D H Huffman, and D L Azarnoff, and R Stephens, and B Hoogstraten
February 1998, The Journal of pharmacy and pharmacology,
S H Wan, and D H Huffman, and D L Azarnoff, and R Stephens, and B Hoogstraten
January 1988, Biopharmaceutics & drug disposition,
S H Wan, and D H Huffman, and D L Azarnoff, and R Stephens, and B Hoogstraten
January 2001, Drug metabolism and drug interactions,
S H Wan, and D H Huffman, and D L Azarnoff, and R Stephens, and B Hoogstraten
December 1983, Journal of pharmacokinetics and biopharmaceutics,
S H Wan, and D H Huffman, and D L Azarnoff, and R Stephens, and B Hoogstraten
January 1986, European journal of clinical pharmacology,
Copied contents to your clipboard!